Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus

Abstract Background Effective antiviral therapy is lacking for most viral infections, and when available, is frequently compromised by the selection of resistance. Targeted protein degraders could provide an avenue to more effective antivirals, able to overcome the selection of resistance. The aim o...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Baolong Pan, Simon J. Mountford, Maki Kiso, Danielle E. Anderson, Georgina Papadakis, Kate E. Jarman, Danielle R. Tilmanis, Belinda Maher, Thomas Tran, Jake Shortt, Seiya Yamayoshi, Yoshihiro Kawaoka, Philip E. Thompson, Sam A. Greenall, Nadia Warner
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Nature Portfolio 2025-04-01
Serie:	Communications Medicine
Accesso online:	https://doi.org/10.1038/s43856-025-00863-1
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!